Li et al., 2017 - Google Patents
Characterization of novel Omp31 antigenic epitopes of Brucella melitensis by monoclonal antibodiesLi et al., 2017
View HTML- Document ID
- 3499635011268688340
- Author
- Li J
- Hu F
- Chen S
- Luo P
- He Z
- Wang W
- Allain J
- Li C
- Publication year
- Publication venue
- BMC microbiology
External Links
Snippet
Background Brucellosis is a severe zoonotic disease worldwide. Detection and identification of Brucella species are essential to prevent or treat brucellosis in humans and animals. The outer membrane protein-31 (Omp31) is a major protein of Brucellae except for B. abortus …
- 102000005614 monoclonal antibodies 0 title abstract description 84
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses, e.g. hepatitis E virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K16/1232—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Escherichia (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100847586B1 (en) | Method for assaying hepatitis c virus | |
Okumura et al. | Development of serological assays for Thottapalayam virus, an insectivore-borne Hantavirus | |
EP1280828A2 (en) | Anthrax-specific antigen, vaccines comprising said antigen, anthrax-specific antibodies, and their uses | |
Zhang et al. | Identification of linear B cell epitope on gB, gC, and gE proteins of porcine pseudorabies virus using monoclonal antibodies | |
Li et al. | Identification and characterization of monoclonal antibodies against the ORFV059 protein encoded by Orf virus | |
Li et al. | Characterization of novel Omp31 antigenic epitopes of Brucella melitensis by monoclonal antibodies | |
Melgoza‐González et al. | Analysis of IgG, IgA and IgM antibodies against SARS‐CoV‐2 spike protein S1 in convalescent and vaccinated patients with the Pfizer‐BioNTech and CanSinoBio vaccines | |
Zhang et al. | Mapping the immunodominance landscape of SARS-CoV-2 spike protein for the design of vaccines against COVID-19 | |
Tian et al. | Broadly neutralizing monoclonal antibodies against human adenovirus types 55, 14p, 7, and 11 generated with recombinant type 11 fiber knob | |
Yang et al. | Evaluation of Reactivity of Monoclonal Antibodies Against Omp25 of Brucella spp. | |
WO2022216223A1 (en) | Vaccine and/or antibody for viral infection | |
Vanhove et al. | XAV-19, a swine glyco-humanized polyclonal antibody against SARS-CoV-2 spike receptor-binding domain, targets multiple epitopes and broadly neutralizes variants | |
Wang et al. | Identification of three conserved linear B cell epitopes on the SARS-CoV-2 spike protein | |
Maghsood et al. | Identification of immunodominant epitopes on nucleocapsid and spike proteins of the SARS-CoV-2 in Iranian COVID-19 patients | |
Hoebe et al. | Purified hexameric Epstein-Barr virus-encoded BARF1 protein for measuring anti-BARF1 antibody responses in nasopharyngeal carcinoma patients | |
KR20220009959A (en) | CSFV subunit vaccine | |
KR20220009960A (en) | Recombinant Classical Swine Fever Virus | |
Mortensen et al. | Identifying protective Streptococcus pyogenes vaccine antigens recognized by both B and T cells in human adults and children | |
WO2021170090A1 (en) | Sars-cov-2 virus detection method and detection kit | |
JP2023546910A (en) | Recombinant classical swine fever virus E2 protein | |
CN111378628A (en) | Hybridoma cell strain secreting mycobacterium tuberculosis ESAT6 protein specific antibody, antibody and application thereof | |
Guillotte et al. | Functional analysis of monoclonal antibodies against the Plasmodium falciparum PfEMP1-VarO adhesin | |
US8492103B2 (en) | Diagnosis and treatment of ehrlichiosis | |
Shi et al. | Preparation and epitope mapping of monoclonal antibodies against African swine fever virus p22 protein | |
Hernández et al. | Monoclonal and Polyclonal Antibodies as Biological Reagents for SARS-CoV-2 Diagnosis Through Nucleocapsid Protein Detection. |